Sponsor study identifier
observational
60
1 country
1
Study Start
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2008
Actual (reported)Study Completion
April 2008
Actual (reported)Glaucoma is a worldwide leading cause of blindness. The key feature of this ocular neuropathy is characterized by an excavating optic nerve head. Loss of retinal ganglion cells is the final end point in blinding diseases of the optic nerve such as glaucoma. It is known that neuronal cell death in glaucoma occurs by apoptotic mechanism. In earlier studies, the investigators demonstrated that the process of apoptosis is reflected in circulating leukocytes by different parameters, like differential messenger ribonucleic acid (mRNA) expression and an increased fragmentation of the deoxyribonucleic acid (DNA). Such alterations point out a relationship between cellular stress and apoptotic events. Based on the results of mRNA-expression, the investigators also expect alterations on the protein level. This study is, therefore, designed to characterize the proteome related to the proteins involved in cell death related pathways. Thus the expression pattern of several proteins in leukocytes from patients with primary open angle glaucoma will be analyzed by techniques like Western-blot and tandem mass spectrometry. These samples will be compared with healthy controls. In addition, they will be also compared with samples from patients with Parkinson's disease. Since glaucoma is a neurodegenerative disease, these patients will be included as a positive control in this study.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
May 17, 2006
Actual (reported)May 18, 2006
Actual (reported)April 2008
Actual (reported)April 2008
Actual (reported)Patients with pseudoexfoliation
University Eye Clinic Basel
Basel, Canton of Basel-City, 4031, Switzerland
Selim Orgül, MD
University Hospital, Basel, Switzerland
60 participants (actual enrollment reported by the registry).
First Submitted
May 17, 2006
First Posted
May 18, 2006
Study Start
June 2005
Date type not reportedThis date has not been verified as actual or estimated.
Serum Citrate in Diagnosis and Follow-up for Glaucoma
Contact the study team to confirm eligibility.
Primary Completion
April 2008
Actual (reported)Study Completion
April 2008
Actual (reported)Last Updated
September 26, 2008
Record last verified: 2008-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: